NSECredit Rating16 Jul 2026 · 16 Jul 2026, 12:17 pm
Credit Rating
Shilpa Medicare Limited · SHILPAMED
✦ AI SummaryRating Change
Shilpa Medicare Limited has informed the Exchange about Credit Rating revision by India Ratings and Research Pvt Ltd (Fitch Group) for its material subsidiary Shilpa Biologicals Private Limited. The revised ratings are IND A+/Stable/IND A1+ for bank loan facilities.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shilpa Medicare Limited has informed the Exchange about Credit Rating
Attachments (1)
📄pdf
Download →
SHILPAMED_16072026121619_SBPL_credit_rating.pdf
View document text
Shilpa Medicare Limited
Corporate & Admin Office:
“Shilpa House”, # 12-6-214/A-1, Hyderabad Road,
Raichur – 584 135, Karnataka, India
Tel: +91-8532-238704, Fax: +91-8532-238876
Email: info@vbshilpa.com, Web: www.vbshilpa.com
CIN: L85110KA1987PLC008739
Date: 16 July 2026
Corporate Relationship Department, National Stock Exchange of India Ltd.
BSE Limited Exchange Plaza, 5th Floor,
Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block
Dalal Street, Fort, Bandra Kurla Complex, Bandra (E)
Mumbai-400 001 Mumbai-400 051
Stock Code: NSE: SHILPAMED/BSE-530549
Dear Sir/Madam,
Sub: Intimation of Revision in Credit Rating of Shilpa Biologicals Private Limited, a Material Subsidiary of Shilpa Medicare
Limited by India Ratings and Research Pvt Ltd (Fitch Group)
Pursuant to Regulations 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 (‘the Regulation’), please find below the details of the revision in credit rating issued by India Ratings and Research
Pvt. Ltd (Fitch Group) for Shilpa Biologicals Private Limited, a Material Subsidiary of Shilpa Medicare Limited:
The instrument-wise ratings are given below:
Shilpa Biologicals Private Limited
Instrument Regulator of Size of Issue Rating assigned along with Rating Action
Type Instruments (million) Outlook/ Watch
Bank loan RBI INR1,250 IND A+/Stable/IND A1+ Assigned
facilities
The said rating is available on the website: https://www.indiaratings.co.in/pressrelease/vvcjm5z7lelcs9xccylo0oms
This is for your information and records.
For SHILPA MEDICARE LIMITED
Ritu Tiwary
Company Secretary & Compliance Officer